Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Secondary focal and segmental glomerulosclerosis associated with single-nucleotide polymorphisms in the genes encoding complement factor H and C3.

Sethi S, Fervenza FC, Zhang Y, Smith RJ.

Am J Kidney Dis. 2012 Aug;60(2):316-21. doi: 10.1053/j.ajkd.2012.04.011. Epub 2012 May 16.

2.

Association of a novel complement factor H mutation with severe crescentic and necrotizing glomerulonephritis.

Fervenza FC, Smith RJ, Sethi S.

Am J Kidney Dis. 2012 Jul;60(1):126-32. doi: 10.1053/j.ajkd.2012.03.007. Epub 2012 Apr 26.

3.

Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies.

Servais A, Noël LH, Roumenina LT, Le Quintrec M, Ngo S, Dragon-Durey MA, Macher MA, Zuber J, Karras A, Provot F, Moulin B, Grünfeld JP, Niaudet P, Lesavre P, Frémeaux-Bacchi V.

Kidney Int. 2012 Aug;82(4):454-64. doi: 10.1038/ki.2012.63. Epub 2012 Mar 28.

4.

Proliferative glomerulonephritis secondary to dysfunction of the alternative pathway of complement.

Sethi S, Fervenza FC, Zhang Y, Nasr SH, Leung N, Vrana J, Cramer C, Nester CM, Smith RJ.

Clin J Am Soc Nephrol. 2011 May;6(5):1009-17. doi: 10.2215/CJN.07110810. Epub 2011 Mar 17.

5.

Dense deposit disease and C3 glomerulopathy.

Barbour TD, Pickering MC, Terence Cook H.

Semin Nephrol. 2013 Nov;33(6):493-507. doi: 10.1016/j.semnephrol.2013.08.002. Review.

6.

C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up.

Sethi S, Fervenza FC, Zhang Y, Zand L, Vrana JA, Nasr SH, Theis JD, Dogan A, Smith RJ.

Kidney Int. 2012 Aug;82(4):465-73.

7.

Risk alleles in CFH and ARMS2 are independently associated with systemic complement activation in age-related macular degeneration.

Smailhodzic D, Klaver CC, Klevering BJ, Boon CJ, Groenewoud JM, Kirchhof B, Daha MR, den Hollander AI, Hoyng CB.

Ophthalmology. 2012 Feb;119(2):339-46. doi: 10.1016/j.ophtha.2011.07.056. Epub 2011 Nov 30.

PMID:
22133792
8.

Podocyte and endothelial injury in focal segmental glomerulosclerosis: an ultrastructural analysis.

Taneda S, Honda K, Ohno M, Uchida K, Nitta K, Oda H.

Virchows Arch. 2015 Oct;467(4):449-58. doi: 10.1007/s00428-015-1821-9. Epub 2015 Aug 13.

9.

IgM as a novel predictor of disease progression in secondary focal segmental glomerulosclerosis.

Pačić A, Šenjug P, Bacalja J, Tišljar M, Horvatić I, Bulimbašić S, Knotek M, Galešić K, Galešić Ljubanović D.

Croat Med J. 2017 Aug 31;58(4):281-291.

10.

Genetic analysis and functional characterization of novel mutations in a series of patients with atypical hemolytic uremic syndrome.

Szarvas N, Szilágyi Á, Csuka D, Takács B, Rusai K, Müller T, Arbeiter K, Réti M, Haris Á, Wagner L, Török S, Kelen K, Szabó AJ, Reusz GS, Morgan BP, Prohászka Z.

Mol Immunol. 2016 Mar;71:10-22. doi: 10.1016/j.molimm.2016.01.003. Epub 2016 Jan 27.

PMID:
26826462
11.

C3 glomerulonephritis associated with a missense mutation in the factor H gene.

Sugimoto K, Fujita S, Miyazaki K, Okada M, Takemura T.

Tohoku J Exp Med. 2012 Jul;227(3):211-5.

12.

Activation of the alternative complement pathway in vitreous is controlled by genetics in age-related macular degeneration.

Loyet KM, Deforge LE, Katschke KJ Jr, Diehl L, Graham RR, Pao L, Sturgeon L, Lewin-Koh SC, Hollyfield JG, van Lookeren Campagne M.

Invest Ophthalmol Vis Sci. 2012 Sep 25;53(10):6628-37.

PMID:
22930722
13.

Novel mutations in NPHP4 in a consanguineous family with histological findings of focal segmental glomerulosclerosis.

Mistry K, Ireland JH, Ng RC, Henderson JM, Pollak MR.

Am J Kidney Dis. 2007 Nov;50(5):855-64.

PMID:
17954299
14.

Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome.

Maga TK, Nishimura CJ, Weaver AE, Frees KL, Smith RJ.

Hum Mutat. 2010 Jun;31(6):E1445-60. doi: 10.1002/humu.21256.

PMID:
20513133
15.

Association study of complement factor H, C2, CFB, and C3 and age-related macular degeneration in a Han Chinese population.

Liu X, Zhao P, Tang S, Lu F, Hu J, Lei C, Yang X, Lin Y, Ma S, Yang J, Zhang D, Shi Y, Li T, Chen Y, Fan Y, Yang Z.

Retina. 2010 Sep;30(8):1177-84. doi: 10.1097/IAE.0b013e3181cea676.

PMID:
20523265
16.

New functional and structural insights from updated mutational databases for complement factor H, Factor I, membrane cofactor protein and C3.

Rodriguez E, Rallapalli PM, Osborne AJ, Perkins SJ.

Biosci Rep. 2014 Oct 22;34(5). pii: e00146. doi: 10.1042/BSR20140117.

17.

Gene polymorphism of complement factor H in a Turkish patient with membranoproliferative glomerulonephritis type II.

Sozeri B, Mir S, Berdeli A, Dincel N, Sarsik B.

Iran J Kidney Dis. 2012 Mar;6(2):149-53.

18.

Pathology of renal diseases associated with dysfunction of the alternative pathway of complement: C3 glomerulopathy and atypical hemolytic uremic syndrome (aHUS).

Sethi S, Fervenza FC.

Semin Thromb Hemost. 2014 Jun;40(4):416-21. doi: 10.1055/s-0034-1375701. Epub 2014 May 5. Review.

PMID:
24799306
19.

Complement alternative pathway genetic variation and Dengue infection in the Thai population.

Kraivong R, Vasanawathana S, Limpitikul W, Malasit P, Tangthawornchaikul N, Botto M, Screaton GR, Mongkolsapaya J, Pickering MC.

Clin Exp Immunol. 2013 Nov;174(2):326-34. doi: 10.1111/cei.12184.

20.

Focal segmental glomerular sclerosis in three generations of a single family.

Sanchez Tomero JA, Arrieta J, Alguacil A, Alonso A, Macias JF, Tabernero JM.

Int J Pediatr Nephrol. 1985 Jul-Sep;6(3):199-204.

PMID:
3902692

Supplemental Content

Support Center